Risk factors for postoperative delayed gastric emptying in ovarian cancer treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy

Table 2 Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy characteristics (n = 77)

Characteristic	Value
Operation time (minute, median and range)	630 (280-960)
Intraoperative hemorrhage (mL, median and range)	600 (50-5000)
Number of organs resected (median and range)	2 (0-9)
Resected organs, n (%)
Ascending colon	18 (23)
Transverse colon	4 (5)
Descending colon	5 (6)
Sigmoid colon	19 (25)
Total colon	3 (4)
Stomach (partial)	3 (4)
Small intestine (partial)	13 (17)
Rectum	46 (60)
Liver (partial)	3 (4)
Spleen	7 (9)
Pancreas (partial)	1 (1)
Gallbladder	8 (10)
Omentectomy, n (%)	56 (73)
Urinary bladder, n (%)	2 (3)
Number of bowel resection, n (%)	53 (69)
PCI (median and range)	16 (1-39)
CCS, n (%)
CC 0-1	60 (78)
CC 2-3	17 (22)
Chemotherapeutic agent, n (%)
Docetaxel	4 (5)
Docetaxel + carboplatin	55 (71)
Mitomycin + docetaxel	4 (5)
Mitomycin + carboplatin	14 (19)

CC: Cytoreduction; CCS: Cytoreduction scoring; PCI: Peritoneal cancer index.